Preston Klassen - Insider Trading & Ownership

Location
3344 N. Torrey Pines Court, Suite 200, La Jolla, CA
Summary
The estimated net worth of Preston Klassen is at least $1.03M dollars as of June 27, 2025. Preston Klassen is the Director of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $651K. Preston Klassen is the President & Head of R & D, Director of Regulus Therapeutics Inc. and owns shares of Regulus Therapeutics Inc. (RGLS) stock worth about $384K.
Signature
/s/ Christopher Aker, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Preston Klassen

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MTCR Metacrine, Inc. Director $651K Mar 23, 2023
RGLS Regulus Therapeutics Inc. President & Head of R & D, Director $384K +$56.1K +17.1% Jun 25, 2025
ZURA Zura Bio Ltd President and COO Mar 20, 2023

Insider Transactions Reported by Preston Klassen:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.